Compare KraneShares CSI China Internet ETF (KWEB) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KraneShares CSI China Internet ETF vs TransMedics Group Inc — how do they compare? KraneShares CSI China Internet ETF trades at $27.07, while TransMedics Group Inc trades at $73.5 (market cap $2.54B). Which is the better fit depends on your goals.
| KWEB | TMDX | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $42.94 | $150.42 |
52-Week Low | $23.63 | $61.99 |
Market Cap | — | $2.54B |
Enterprise Value | — | $2.94B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KWEB is trading at $27.44, up 2.35% with bullish technical signals from moving averages. The ETF shows strong momentum with RSI indicators mixed but ADX suggesting trend strength. Recent news highlights China's focus on AI and technology sectors, with export controls and IPO activity creating both opportunities and regulatory uncertainties for Chinese internet companies.
The outlook remains cautiously optimistic given China's tech ambitions and attractive valuations, though geopolitical tensions and regulatory risks require careful monitoring. AI-driven growth potential is balanced by ongoing US-China trade tensions that could impact constituent companies.
TransMedics (TMDX) is trading at $73.47, down 0.69% on the day, amid a mixed technical and fundamental backdrop. The stock shows neutral technical signals with support near $72 and resistance at $75, while fundamentals are strong with a trailing P/E of 16.81 and robust profitability metrics like a 27.04% net income margin. Recent earnings saw a Q1 2026 miss but beats in prior quarters, and the company is expanding in Europe through strategic investments.
The outlook is cautiously optimistic with a consensus price target of $108.71 implying significant upside, supported by 75% analyst buy ratings. Key risks include margin pressure from expansion costs and competitive threats, but the company's organ transplant logistics network offers a durable competitive advantage for long-term growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KraneShares CSI China Internet ETF
KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
